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Abstract
Context: Dementia care giving can lead to increased stress, physical and psychosocial morbidity, and mortality.
Anecdotal evidence suggests that hospice care provided to people with dementia and their caregivers may buffer
caregivers from some of the adverse outcomes associated with family caregiving in Alzheimer’s Disease (AD).
Objectives: This pilot study examined psychological and physical outcomes among 32 spousal caregivers of
patients with AD. It was hypothesized that caregivers who utilized hospice services would demonstrate better
outcomes after the death of their spouse than caregivers who did not utilize hospice.
Methods: The charts of all spousal caregivers enrolled in a larger longitudinal study from 2001 to 2006 (N = 120)
were reviewed, and participants whose spouse had died were identified. Of these, those who received hospice
care (n= 10) were compared to those who did not (n= 22) for various physiological and psychological measures
of stress, both before and after the death of the care recipient. An Analysis of Covariance (ANCOVA), with
postdeath scores as the dependent variable and pre-death scores as covariates, was used for all variables.
Results: Significant group differences were found in postdeath depressive symptoms (HAM-D; F(1,29) = 6.10,
p < 0.05) and anxiety symptoms (HAM-A; F(1,29) = 5.71, p < 0.05). Most psychological outcome variables dem-
onstrated moderate effect sizes with a Cohen’s d of > 0.5 between groups.
Conclusions: These data suggest that hospice enrollment may ameliorate the detrimental psychological effects in
caregivers who have lost a spouse with Alzheimer’s Disease. Based on these pilot data, further prospective
investigation is warranted.
Introduction
Caregivers of patients with Alzheimer’s Disease (AD)experience chronic stress, placing them at increased risk
for both psychological and physical morbidity. Compared to
their noncaregiving counterparts, these caregivers are more
likely to experience symptoms of depression,1 anxiety,2 and
anger/frustration,3 as well as reduced well-being,4 impaired
sleep,5,6 poorer self-rated health,7 increased cardiovascular
disease,8–11 and premature death.12 Further, dementia care-
givers are more likely to experience emotional or physical
problems relative to nondementia caregivers.13 Given the re-
lationship between psychological distress, cardiac health, and
the development of cardiovascular disease,14–17 it seems likely
that alleviating caregivers’ distress might have beneficial im-
pacts on their own long-termphysical health, aswell as on their
ability to provide care. AD caregivers who had placed their
spouse in a long-term care facility experienced improvements
in psychological distress, physical symptoms, and cardiovas-
cular health, relative to those caregivers continuing in-home
care, likely due to reduced exposure to the chronic stress of in-
home caregiving.18,19
Hospice care seeks to improve quality of life and reduce
suffering at the end of life for seriously ill patients and their
caregivers.20,21 Psychological and physical distress related to
caring for someone with an advanced, life-threatening illness,
such as Alzheimer’s dementia, is an important target of hos-
pice care. Currently, 5.4 million U.S. adults suffer from AD,
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which, in its final stages, is now considered a terminal ill-
ness.22,23 Care for people with AD is provided by 14.9 million
caregivers, accounting for $183 billion in annual costs.23
Caregiver stress is common and costly, as well as a major
source of suffering for patients and families. In this context,
effective strategies to reduce the distress associated with
family caregiving in AD have the potential to significantly
impact quality of life and health outcomes in this large pop-
ulation, while reducing health care costs.
This preliminary pilot investigation examined whether
hospice care may ameliorate some of the psychological and
physiologic stresses associated with caregiving for a spouse
suffering from AD.
Methods
Participants
Subjects were drawn from a larger, longitudinal investi-
gation that prospectively assessed psychological and phys-
ical health outcomes for a cohort of 120 elderly spousal
caregivers of people with AD, during the five-year study
period from 2002 to 2006. Detailed methods for the larger
study are provided elsewhere.19 Subjects had participated in
this larger study at the University of California, San Diego
(UCSD) Alzheimer’s Disease Research Center. All partici-
pants provided in-home care for their spouse with AD, were
at least 55 years of age, and were free of serious medical
conditions at the time of enrollment. Participants were ex-
cluded if they were caring for a friend, a sibling, a child, or
otherwise were not caring for a spouse. Additional exclusion
criteria included the use of beta-blocker or anticoagulant
medication, or uncontrolled hypertension, as these were
potential confounders for biological outcomes assessed in
the parent project. The UCSD institutional review board
approved the protocol, and all participants provided written
informed consent prior to enrollment.
The charts of all caregivers enrolled in the parent study
(n = 120) were reviewed, and participants whose spouse with
AD died during the five-year study period were identified
(n = 32); these 32 caregivers served as the subjects in the
present report. This report compares changes in pre-death to
postdeath psychological and physiological outcomes for
participants in the parent study who reported hospice en-
rollment for their spouse (n = 10) as compared to those who
did not use hospice services (n = 22).
Procedures
In the parent longitudinal study, research staff conducted
face-to-face assessments of caregivers at 12-month intervals.
In addition, regular check-in phone calls were made every six
months to inquire about changes in health status and transi-
tions in caregiving (i.e., placement of the AD spouse in long-
term care or death of the AD patient). After any reported
transition in caregiving, an additional follow-up assessment
was scheduled within six months.
Measures
A detailed description of the measures used for demo-
graphic and outcomes variables is provided elsewhere.19
Briefly, demographics included age, gender, ethnicity, years
of education, and income. Dementia severity (of the person
with AD) was assessed using the Clinical Dementia Rating
Scale.24 The primary psychological outcomes included
symptoms of depression and anxiety, as measured by the 17-
item Hamilton Rating Scale for Depression (HAM-D)25,26 and
the 14-item Hamilton Rating Scale for Anxiety (HAM-A).27
Modes of caregiver coping were measured using the Avoid-
ance Coping subscale of the Ways of Coping instrument,28
since this coping strategy has beenmost consistently linked to
psychological morbidity and decreased well-being.29 Assess-
ments of physical health included the following: (1) an overall
health outcomes score derived from a semistructured inter-
view assessing participants’ health outcomes over the prior
six months; (2) resting blood pressure and heart rate; and (3)
hemodynamic reactivity to stress, as measured by response of
blood pressure and heart rate to a simulated stressor.30,31 Fi-
nally, caregiver sleep was evaluated using the Global Sleep
Quality Score of the Pittsburgh Sleep Quality Index (PSQI).32
All instruments were administered by research staff and
based on participants’ self-report of symptoms.
Data analyses
Change in the dependent variables from pre-death to
postdeath was analyzed using Analyses of Covariance
(ANCOVAs), with postdeath scores as the dependent variable
and pre-death scores as covariates, controlling for the effect of
pre-death differences on outcome measures. This analysis
used pre-death and postdeath measures most proximate to
the spouse’s death (i.e., the set of measures immediately be-
fore and immediately after the spouse’s death). For heart rate
and blood pressure reactivity, residualized change scores (i.e.,
the posttest score as a deviation from the posttest-on-pretest
regression line)32,33 were created and the postdeath score was
used as the dependent variable, with pre-death scores as
covariates. Hospice involvement was used as the primary
predictor in all analyses. Due to the small sample size, effect
sizes for group mean differences (Cohen’s d) were calculated
for all outcome variables in this study. For statistical tests,
significance was assumed at the p< 0.05 level.
Results
Pre-death demographic data, scores of dementia severity,
and baseline blood pressuremeasurements for all participants
are presented in Table 1. Caregivers who utilized hospice
were more highly educated (16.1 – 1.85 years versus
14.18– 1.76 years; t(30)= 2.81; p < 0.01) and showed a trend
toward higher incomes. No other significant baseline differ-
ences were observed, including depressive symptoms
( p = 0.314), anxiety symptoms ( p= 0.356), avoidance coping
( p = 0.759), health symptoms ( p = 0.710), SBP ( p = 0.702), or
DBP ( p= 0.966).
After controlling for differences in pre-death outcomes
scores, significant group differences were found in postdeath
symptoms of depression and anxiety as measured by the
HAM-D andHAM-A, respectively (see Figure 1). Specifically,
caregivers who utilized hospice reported lower postdeath
symptoms of depression (2.2 – 0.55 versus 5.73 – 1.18;
F(1,29)= 6.10, p < 0.05) and anxiety (3.70 – 1.16 versus
6.14 – 1.12; F(1,29)= 5.71, p < 0.05), compared to those who did
not use hospice. No group differences were observedwith use
of avoidance coping, physical health measures (overall health
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outcomes, or blood pressure or heart rate reactivity), or sleep
quality. Table 2 provides depictions of raw depressive
symptoms, anxiety symptoms, and health outcomes scores
(pre- and postdeath) by group, as well as Cohen’s d values.
On average, the postdeath assessment occurred 7.3 months
after the death of the spouse (SD = 1.3 months). Including this
variable as a covariate in the analysis did not significantly
predict HAM-D scores ( p= 0.493). Also, hospice condition
remained significant ( p = 0.022).
Discussion
This pilot investigation was aimed at providing prelimi-
nary evidence for the relationship between hospice care and
the well-being of family caregivers for patients with AD. The
data reported here suggest an association between hospice
enrollment and decreased psychological distress in these
caregivers, specifically with reductions in symptoms of de-
pression and anxiety. The data failed to show a relationship to
several physical health outcomes, coping strategies, or sleep
quality.
Caution should be used in interpreting these findings, gi-
ven the small sample size and nonexperimental design of the
study. Only a small number of caregivers experienced the
death of their spouse during the study period, and even fewer
utilized hospice care. Recruitment from a single geographic
region also limits generalizability. Similarly, participants
were not randomized to exposure groups, and other meth-
odological strategies to control for baseline differences be-
tween the groups were not prospectively incorporated into
the study design. For these reasons, alternative explanations
for the results cannot be ruled out, such as baseline (pre-
death) group differences that might account for hospice uti-
lization and influence change in psychological distress.
Despite these limitations, these data point to potentially
fruitful areas of further investigation. Larger, experimental
studies are needed to validate and further characterize the
relationships suggested by the results of this pilot study. For
example, the effects of specific hospice care elements on
psychological distress should be explored in order to inform
effective strategies for caregiver support in this population.
Specifically, does the location of hospice care (in-home versus
inpatient, for example) influence the amelioration of psycho-
logical stress? Do specific elements of bereavement care (in-
dividual counseling versus support groups, for example)
affect psychological benefits associated with hospice use?
FIG. 1. Change from pre- to postdeath by hospice and non-
hospice groups– standard error for (A) depression symptoms,
(B) anxiety symptoms, and (C) health outcomes. * p<0.05.
Table 1. Pre-Death Demographic Characteristics of Caregivers
Who Did and Did Not Utilize Hospice Services
No hospice (n = 22) Hospice (n = 10) t-value, x2 p-value
Age, mean (SD) 73.95 (8.85) 76.80 (8.68) - 0.85 0.403
Monthly income, mean (SD) $3,763.60 ($1,613.08) $5,761.86 ($3,899.06) - 1.92 0.067
Years of education, mean (SD) 14.18 (1.76) 16.10 (1.85) - 2.81 0.009*
Clinical Dementia Rating Scale score, n (%)
Mild 4 (18.2) 1 (10.0) 1.05 0.592
Moderate 7 (31.8) 5 (50.0)
Severe 11 (50.0) 4 (40.0)
Systolic Blood Pressure 132.90 (17.58) 135.13 (15.07) - 0.39 0.702
Diastolic Blood Pressure 65.98 (9.30) 65.94 (11.37) 0.043 0.966
*p< 0.05
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Does the duration of engagement in hospice influence psy-
chological benefits? A larger study with more robust methods
would allow an exploration of these important questions. Si-
milarly, this data suggests a trend toward significance in health
outcomes scores ( p= 0.07). Whether or not hospice participa-
tionmay also confer some physical health benefits to caregivers
deserves further study and attention in more robust trials.
Although preliminary in nature, the data from this study
suggest a relationship between hospice care and caregiver
psychological well-being. The consequences of unrelieved
psychological distress are substantial: depressive symptoms,
for example, have been shown to contribute to the develop-
ment of cardiovascular disease in caregivers19 as well as to
increased cardiovascular morbidity and mortality in the
general population.34 Moreover, increased symptoms of de-
pression and/or anxiety, if not detected or addressed, can
increase the perceived severity of pain and other physical
symptoms;35–38 affect physical health and quality of life;35,39
impair decision making; impact the relationship with a care
recipient, and significantly increase the probability of mor-
bidity, mortality,40 and suicide.41–45 Effective strategies to
ameliorate psychological distress, particularly in the setting of
caregiving for family members with AD, are likely to have a
profound impact on the end-of-life experiences of these pa-
tients and their family members. Hospice care may serve as a
model to deliver such interventions and thereby support
caregivers in this final phase of caring for loved ones with AD.
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